2022 / 05

Next Paper
DOI: 10.24075/brsmu.2022.047

ORIGINAL RESEARCH

Geographic distribution of the LZTFL1 SNP markers associated with severe COVID-19 in Russia and worldwide

Balanovska EV1,2, Gorin IO1, Petrushenko VS1, Chernevskiy DK1, Koshel SM1,3, Temirbulatov II1,4, Pylev VYu1,2, Agdzhoyan AT1
About authors

1 Research Centre for Medical Genetics, Moscow, Russia

2 Autonomous non-profit organization “Biobank of North Eurasia”, Moscow, Russia

3 Lomonosov Moscow State University, Moscow, Russia

4 Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow, Russia

Correspondence should be addressed: Elena V. Balanovska
Moskvorechye, 1, 115522, Moscow, Russia; ur.liam@aksvonalab

About paper

Funding: the study was supported by the Russian Science Foundation grant № 21-14-00363 (bioinformatics analysis, cartographic analysis) and performed within the State Assignment of the Ministry of Science and Higher Education of the Russian Federation for the Research Centre for Medical Genetics (statistical analysis, data interpretation, manuscript writing).

Acknowledgements: the authors express their gratitude to all members of the expedition survey of the North Eurasian indigenous population (sample donors) and the autonomous non-profit organization “Biobank of North Eurasia” for access to DNA collections, and Olkova MV, for her participation in gathering information on the gene variants associated with the COVID-19 severity.

Author contribution: Balanovska EV — data analysis, manuscript writing, research management; Gorin IO, Petrushenko VS — bioinformatics analysis; Agdzhoyan AT, Chernevsky DK, Pylev VYu — statistical analysis; Temirbulatov II — explanation of pharmacogenetic approaches; Koshel SM — cartographic analysis.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Research Centre for Medical Genetics (protocol № 1 of 29 June 2020); all subjects submitted the informed consent to study participation.

Received: 2022-09-13 Accepted: 2022-09-28 Published online: 2022-10-23
|
  1. The COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021; 600: 472–7. DOI: 10.1038/s41586-021-03767-x.
  2. COVID19-hg GWAS meta-analyses round 6. The COVID-19 Host Genetics Initiative. [cited 2022 Sep 13]. Available from: https:// www.covid19hg.org/results/r6/.
  3. Downes DJ, Cross AR, Hua P, Roberts N, Schwessinger R, Cutler AJ, et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet. 2021; 53: 1606–15. DOI: 10.1038/s41588-021-00955-3.
  4. Vologzhanin DA, Golota AS, Kamilova TA, Shneider OV, Sherbak SG. Genetics of COVID-19. Journal of Clinical Practice. 2021; 12 (1): 41–52. DOI: 10.17816/clinpract64972. Russian.
  5. Bardet-Biedl syndrome-17; BBS17. Online Mendelian Inheritance in Man — OMIM. [cited 2021 Nov 25]. Available from: https:// omim.org/entry/615994.
  6. Waters AM, Beales PL. Ciliopathies: an expanding disease spectrum. Pediatr Nephrol. 2011; 26: 1039–56. DOI: 10.1007/ s00467-010-1731-7.
  7. Potrokhova EA, Babayan ML, Baleva LS, Safonova MP, Sipyagina AE. Bardet–Biedl Syndrome. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020; 65 (6): 76– 83. DOI: 10.21508/1027-4065-2020-65-6-76-83. Russian.
  8. Seo S, Zhang Q, Bugge K, Breslow DK, Searby CC, Nachury MV, et al. A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. PLoS Genet. 2011; 7 (11): e1002358. DOI: 10.1371/journal.pgen.1002358.
  9. GeneCards: The Human Gene Database [Internet]. Rehovot, Israel: Weizmann Institute of Science. c1996-2022 — LZTFL1 Gene — Leucine Zipper Transcription Factor Like 1; [cited 2022 Sep 12]. Available from: https://www.genecards.org/cgi-bin/ carddisp.pl?gene=LZTFL1.
  10. Klink BU, Gatsogiannis C, Hofnagel O, Wittinghofer A, Raunser S. Structure of the human BBSome core complex. eLife. 2020; 9: e53910. DOI: 10.7554/eLife.53910.
  11. Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021; 131 (23): e152386. DOI: 10.1172/JCI152386.
  12. Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. Engl J Med. 2020; 383 (16): 1522–34. DOI: 10.1056/NEJMoa2020283.
  13. Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021; 591 (7848): 92–8. DOI: 10.1038/s41586-02003065-y.
  14. Balanovsky О, Petrushenko V, Mirzaev K, Abdullaev S, Gorin I, Chernevskiy D, et al. The variation of genome sites associated with severe COVID-19 across populations the worldwide and national patterns. Pharmgenomics Pers Med. 2021; 14: 1391– 402. DOI: 10.2147/PGPM.S320609.
  15. Secolin R, de Araujo TK, Gonsales MC, Rocha CS, Naslavsky M, Marco L, et al. Genetic variability in COVID-19-related genes in the Brazilian population. Hum Genome Var. 2021; 8 (15). DOI: 10.1038/s41439-021-00146-w.
  16. Balanovska EV, Zhabagin MK, Agdjoyan AT, Chuhryaeva MI, Markina NV, Balaganskaya OA, et al. Population biobanks: Organizational models and prospects of application in gene geography and personalized medicine . Russ J Genet. 2016; 52 (12): 1227–43. DOI: 10.1134/S1022795416120024.
  17. Gorin IO, Petrushenko VS, Zapisetskaya YS, Koshel SM, Balanovsky OP. Application of the population biobank for analysis of the distribution of the clinically significant DNA markers in the Russian populations: bioinformatic aspects. Cardiovascular Therapy and Prevention. 2020; 19 (6): 2732. DOI: 10.15829/17288800-2020-2732. Russian.
  18. GG-base [cited 2022 Sep 10]. Available from: https://gg-base.org/.